收稿日期: 2025-12-04
网络出版日期: 2026-04-28
基金资助
国家重点研发计划(2022YFC2405600);南通市社会民生科技计划项目(MSZ2024090);南通市卫生健康委科研项目(MS2024029)
Mediating effect of sleep quality on the relationship between cerebral small vessel disease and cognitive function among older adults in Nantong
Received date: 2025-12-04
Online published: 2026-04-28
目的 探讨睡眠质量在南通市老年人脑小血管病(cerebral small vessel disease, CSVD)与认知功能间的中介效应。 方法 回顾性分析2024年3月至2025年3月在南通市第一人民医院神经内科住院的412例南通市60岁及以上CSVD患者的临床资料。采用蒙特利尔认知评估量表(Montreal Cognitive Assessment, MoCA)评估认知功能,根据结果分为认知障碍(cognitive impairment, CI)组和非CI组进行比较。采用匹兹堡睡眠质量指数量表(Pittsburgh Sleep Quality Index, PSQI)评估睡眠质量。采用多元线性回归分析确定关键变量之间的关系。通过宏程序PROCESS 4.1插件中的Model 4进行睡眠质量在CSVD与认知功能间的中介效应分析,使用Bootstrap法进行中介效应验证。 结果 CI患者192例(46.6%),非CI患者220例(53.4%),CI组与非CI组患者相比,CSVD负担较重、腔隙、中-重度白质高信号(white matter hyperintensities, WMH)、脑微出血(cerebral microbleed, CMB)、>10个基底节区-血管周围间隙扩大(basal ganglia-enlarged perivascular spaces, BG-EPVS)比例较高、PSQI评分较高,差异均有统计学意义(均P < 0.05或P < 0.001)。在调整协变量年龄、性别、受教育年限、汉密尔顿焦虑量表(Hamilton Anxiety Scale, HAMA)评分、17项-汉密尔顿抑郁量表(Hamilton Depression Rating Scale-17, HAMD-17)评分及血管危险因素后,CSVD负担、腔隙数量、CMB数量、BG-EPVS数量、WMH严重程度与MoCA评分均呈显著负相关(均P < 0.001),与PSQI评分均呈显著正相关(均P < 0.05或P < 0.001);PSQI评分与MoCA评分呈显著负相关(P < 0.001)。中介效应分析结果表明,睡眠质量在CSVD与认知功能关系中起部分中介效应,其在CSVD负担、腔隙、WMH、CMB、BG-EPVS与认知功能关系中的中介效应占比分别为15.2%、15.8%、21.7%、16.7%、23.0%,经Bootstrap检验(5 000次),95%CI的上、下限均不包含0,中介效应显著。 结论 睡眠质量在南通市老年人CSVD导致CI的过程中起着部分中介效应,改善睡眠质量可能有助于降低CSVD-CI的发生风险。
郭啸鸣 , 曹志勇 , 陆珍辉 , 顾津瑜 , 邢灿 , 朱向阳 . 睡眠质量在南通市老年人脑小血管病与认知功能间的中介效应[J]. 实用医学杂志, 2026 , 42(8) : 1421 -1427 . DOI: 10.3969/j.issn.1006-5725.2026.08.016
Objective To explore the mediating effect of sleep quality on the relationship between cerebral small vessel disease (CSVD) and cognitive function among the older adults in Nantong. Methods A total of 412 patients aged 60 years or above with CSVD admitted to the Department of Nantong First People's Hospital in Nantong from March 2024 to March 2025 were enrolled in this retrospective study. Based on the cognitive function assessed by the Montreal Cognitive Assessment (MoCA), patients were divided into the cognitive impairment (CI) group and the non-CI group for comparison. Sleep quality was evaluated using the Pittsburgh Sleep Quality Index (PSQI). Multiple linear regression analysis was conducted to determine the relationships among key variables. The mediating effect of sleep quality between CSVD and cognitive function was analyzed using Model 4 of the PROCESS macro version 4.1, and the mediating effect was validated through the Bootstrap method. Results There were 192 patients (46.6%) with CI, and 220 patients (53.4%) without CI. Patients in the CI group presented a greater burden of CSVD, higher proportions of lacunes, moderate-to-severe white matter hyperintensities (WMH), cerebral microbleed (CMB), and basal ganglia-enlarged perivascular spaces (BG-EPVS) exceeding 10, as well as elevated PSQI scores compared to the non-CI group. All these differences were statistically significant (all P < 0.05 or P < 0.001). After adjusting for covariates such as age, sex, years of education, Hamilton Anxiety Scale (HAMA) scores, Hamilton Depression Rating Scale-17 (HAMD-17) scores, and vascular risk factors, the CSVD burden, the number of lacunes, the number of CMB, the number of BG-EPVS, and the severity of WMH were all significantly negatively correlated with Montreal Cognitive Assessment (MoCA) scores (all P < 0.001), and significantly positively correlated with PSQI scores (all P < 0.05 or P < 0.001). Additionally, PSQI scores were significantly negatively correlated with MoCA scores (P < 0.001). Mediated effect analysis indicated that sleep quality plays a partial mediating role in the relationship between CSVD and cognitive function. The mediating effect ratios in the relationships between CSVD burden, lacunes, WMH, CMB, BG-EPVS and cognitive function are 15.2%, 15.8%, 21.7%, 16.7% and 23.0% respectively. In the Bootstrap test (5 000 times), neither the upper nor the lower limit of the 95% confidence interval contains 0, suggesting that the mediating effect is significant. Conclusions Sleep quality plays a partial mediating role in the process by which CSVD leads to CI among the elderly in Nantong. Enhancing sleep quality may be beneficial in reducing the risk of developing CSVD-CI.
Key words: cerebral small vessel disease; cognitive; sleep quality; mediating effect; burden
| [1] | SEMYACHKINA-GLUSHKOVSKAYA O, POSTNOV D, PENZEL T, et al. Sleep as a novel biomarker and a promising therapeutic target for cerebral small vessel disease: A review focusing on Alzheimer's disease and the blood-brain barrier[J]. Int J Mol Sci, 2020, 21(17): 6293. doi:10.3390/ijms21176293 . |
| [2] | 中国研究型医院学会脑小血管病专业委员会《中国脑小血管病诊治专家共识》编写组. 中国脑小血管病诊治专家共识2021[J]. 中国卒中杂志, 2021, 16(7): 716-726. doi:10.3969/j.issn.1673-5765.2021.07.013 . |
| [3] | 黄翌, 卢显晶, 王晗. 南通市连续三次人口普查老龄化率位居全国第一的原因、趋势、对策及对其他地区的启示[J]. 老龄科学研究, 2023, 11(1): 44-55. doi:10.3969/j.issn.2095-5898.2023.01.006 . |
| [4] | 马晓蓉, 张静宜, 宗运之, 等. 无创呼吸机治疗对阻塞性睡眠呼吸暂停低通气综合征患者骨钙素和认知功能障碍的影响[J]. 实用医学杂志, 2023, 39(2): 249-254. doi:10.3969/j.issn.1006-5725.2023.02.021 . |
| [5] | MENG W, GAO T, ZHONG Y, et al. Association between sleep and cognition of older adults in rural areas: A cross-sectional study[J]. Inquiry, 2023, 60: 00469580231171820. doi:10.1177/00469580231171820 . |
| [6] | SARSEMBAYEVA D, SCHREUDER M J, HUISMAN M, et al. Individual sleep problems are associated with an accelerated decline in multiple cognitive functions in older adults[J]. J Sleep Res, 2025, 34(5): e70067. doi:10.1111/jsr.70067 . |
| [7] | ZHAO J, KONG Q, ZHOU X, et al. Differences in gray matter volume in cerebral small vessel disease patients with and without sleep disturbance[J]. Brain Sci, 2023, 13(2): 294. doi:10.3390/brainsci13020294 . |
| [8] | ZHAO J, KONG Q, WANG M, et al. Association of excessive daytime sleepiness with cerebral small vessel disease in community-dwelling older adults[J]. Nat Sci Sleep, 2022, 14: 765-773. doi:10.2147/NSS.S357586 . |
| [9] | WANG J, LIU S, ZHAO C, et al. Effects of trazodone on sleep quality and cognitive function in arteriosclerotic cerebral small vessel disease comorbid with chronic insomnia[J]. Front Psychiatry, 2020, 11: 620. doi:10.3389/fpsyt.2020.00620 . |
| [10] | DEL BRUTTO O H, MERA R M, ZAMBRANO M, et al. Poor sleep quality and silent markers of cerebral small vessel disease: A population-based study in community-dwelling older adults (The Atahualpa Project)[J]. Sleep Med, 2015, 16(3): 428-431. doi:10.1016/j.sleep.2014.10.023 . |
| [11] | YANG S, YIN J, QIN W, et al. Poor sleep quality associated with enlarged perivascular spaces in patients with lacunar stroke[J]. Front Neurol, 2022, 12: 809217. doi:10.3389/fneur.2021.809217 . |
| [12] | LI X, QIN R R, CHEN J, et al. Neuropsychiatric symptoms and altered sleep quality in cerebral small vessel disease[J]. Front Psychiatry, 2022, 13: 882922. doi:10.3389/fpsyt.2022.882922 . |
| [13] | ZUURBIER L A, IKRAM M A, LUIK A I, et al. Cerebral small vessel disease is related to disturbed 24-h activity rhythms: A population-based study[J]. Eur J Neurol, 2015, 22(11): 1482-1487. doi:10.1111/ene.12775 . |
| [14] | 张莉, 傅蕴婷. 脑小血管病患者血清磷酸化Tau蛋白-181、γ-谷氨酰转肽酶、沉默信息调节因子1与睡眠障碍的相关性[J]. 实用医学杂志, 2025, 41(12): 1867-1872. doi:10.3969/j.issn.1006-5725.2025.12.014 . |
| [15] | STAALS J, MAKIN S D J, DOUBAL F N, et al. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden[J]. Neurology, 2014, 83(14): 1228-1234. doi:10.1212/WNL.0000000000000837 . |
| [16] | 路桃影, 李艳, 夏萍, 等. 匹兹堡睡眠质量指数的信度及效度分析[J]. 重庆医学, 2014, 43(3): 260-263. doi:10.3969/j.issn.1671-8348.2014.03.002 . |
| [17] | JIA X, WANG Z, HUANG F, et al. A comparison of the Mini-Mental State Examination (MMSE) with the Montreal Cognitive Assessment (MoCA) for mild cognitive impairment screening in Chinese middle-aged and older population: A cross-sectional study[J]. BMC Psychiatry, 2021, 21(1): 485. doi:10.1186/s12888-021-03495-6 . |
| [18] | CAI Y, ZHANG Y, LENG S, et al. The relationship between inflammation, impaired glymphatic system, and neurodegenerative disorders: A vicious cycle[J]. Neurobiol Dis, 2024, 192: 106426. doi:10.1016/j.nbd.2024.106426 . |
| [19] | ANG P S, ZHANG D M, AZIZI S A, et al. The glymphatic system and cerebral small vessel disease[J]. J Stroke Cerebrovasc Dis, 2024, 33(3): 107557. doi:10.1016/j.jstrokecerebrovasdis.2024.107557 . |
| [20] | HAYDEN M R. Brain endothelial cell activation and dysfunction associate with and contribute to the development of enlarged perivascular spaces and cerebral small vessel disease[J]. Histol Histopathol, 2024, 39(12): 1565-1586. doi:10.14670/HH-18-792 . |
| [21] | TANG J, ZHANG M, LIU N, et al. The association between glymphatic system dysfunction and cognitive impairment in cerebral small vessel disease[J]. Front Aging Neurosci, 2022, 14: 916633. doi:10.3389/fnagi.2022.916633 . |
/
| 〈 |
|
〉 |